FRANKFURT, March 10 (Reuters) - The two cofounders and leading executives of Germany's BioNTech will leave the COVID-19 vaccine maker by the end of 2026 to set up their own company, the biotech firm ...
SyndicateRoom, the data-driven venture capital fund manager, has recorded a tenfold (10x) increase in investor enquiries specifically targeting ‘carry back’ ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する